News

Phantom "patient financial responsibility" could affect the sustainability of the ICHRA market.

The Learning Resources v. Trump opinion will affect regulators' efforts to do anything not explicitly described in federal laws.

"Across services, drugs and inputs, the United States consistently pays substantially higher prices than its peers for comparable services, drug and inputs," according to a new report in Health Affairs.

The action is part of President Donald Trump's Great American Recovery Initiative, established by executive order on Jan. 15, a federal effort aimed at expanding treatment access and ensuring patients can seek help without fear of discrimination.

The Wall Street Journal reported that UnitedHealth shareholders were not told about these investments, which totaled tens of millions of dollars.

DOL officials wanted PBMs to share the costs, but the new transparency mandate law prohibits PBMs from paying the auditors.